Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy

M. Luisa Corvo, Ana Soraia Mendo, Sara Figueiredo, Rogerio Gaspar, Miguel Larguinho, M. Fatima C. Guedes da Silva, Pedro Miguel Ribeiro Viana Baptista, Maria Alexandra Núncio de Carvalho Ramos Fernandes

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Tin complexes demonstrate antiproliferative activities in some case higher than cisplatin, with IC50 at the low micromolar range. We have previously showed that the cyclic trinuclear complex of Sn(IV) bearing an aromatic oximehydroxamic acid group [nBu(2)Sn(L)](3) (L=N,2-dihydroxy-5-[N-hydroxyethanimidoyl]benzamide) (MG85) shows high anti-proliferative activity, induces apoptosis and oxidative stress, and causes destabilization of tubulin microtubules, particularly in colorectal carcinoma cells. Despite the great efficacy towards cancer cells, this complex still shows some cytotoxicity to healthy cells. Targeted delivery of this complex specifically towards cancer cells might foster cancer treatment.

MG85 complex was encapsulated into liposomal formulation with and without an active targeting moiety and cancer and healthy cells cytotoxicity was evaluated.

Encapsulation of MG85 complex in targeting PEGylated liposomes enhanced colorectal carcinoma (HCT116) cancer cell death when compared to free complex, whilst decreasing cytotoxicity in non-tumor cells. Labeling of liposomes with Rhodamine allowed assessing internalization in cells, which showed significant cell uptake after 6 h of incubation. Cetuximab was used as targeting moiety in the PEGylated liposomes that displayed higher internalization rate in HCT116 cells when compared with non-targeted liposomes, which seems to internalize via active binding of Cetuximab to cells.

The proposed formulation open new avenues in the design of innovative transition metal-based vectorization systems that may be further extended to other novel metal complexes towards the improvement of their anti-cancer efficacy, which is usually hampered by solubility issues and/or toxicity to healthy tissues.

Original languageEnglish
Pages (from-to)1351-1358
Number of pages8
JournalPharmaceutical Research
Volume33
Issue number6
DOIs
Publication statusPublished - Jun 2016

Keywords

  • (targeted) long circulating liposomes
  • antiproliferative
  • colorectal carcinoma
  • Sn(IV) complexes
  • ORGANOTIN COMPOUNDS
  • CETUXIMAB THERAPY
  • DRUG-DELIVERY
  • IN-VITRO
  • DOXORUBICIN
  • EFFICACY
  • DESIGN
  • AGENTS

Cite this